ANI Pharmaceuticals receives FDA nod for Cortrophin Gel in 1-ml vial size
Cortrophin Gel is the only FDA-approved purified corticotropin indicated for the treatment of appropriate patients with acute gouty arthritis flares.
The Food and Drug Administration has granted ANI Pharmaceuticals permission for its new 1-ml vial size of Purified Cortrophin Gel.
Cortrophin Gel is the only FDA-approved purified corticotropin indicated for the treatment of appropriate patients with acute gouty arthritis flares.
[Read more: ANI Pharmaceuticals launches 2 generics]
The product is available through distributors to help enable in-office administration and through specialty pharmacies.
Cortrophin Gel will now be available in two sizes, including the 5-ml vial size launched in January 2022.
[Read more: ANI Pharmaceuticals receives FDA nod for generic Furadantin]